Watch this on-demand webinar to learn about the cell avidity technology advancing CAR-T cell therapy research
Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease
A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine
Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy
Adults who have received a double vaccination are 47% less likely to have long COVID
Research led by Queen’s University Belfast has shown that dogs can predict epileptic seizures, offering a warning sign to owners that has the potential to save lives
Gain insights on topics from pleural fluid analysis, CRISPR technologies, trace element analysis in food products & more
Industry experts discuss the role of artificial intelligence in the fight against COVID-19, the lessons learned and its future promise in healthcare
Keep up to date with the latest technologies and techniques advancing clinical diagnostics
The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)
Gain insights on topics from point-of-care cardiac troponin, CRISPR editing efficiency, targeted biomarker measurements for precision medicine & more
Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home
Researchers have cataloged for the first time
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation
The company plans to interface the algorithm into the Atellica Data Manager software in the future
